0001104659-23-026139.txt : 20230227
0001104659-23-026139.hdr.sgml : 20230227
20230227180834
ACCESSION NUMBER: 0001104659-23-026139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230224
FILED AS OF DATE: 20230227
DATE AS OF CHANGE: 20230227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Appelhans Dannielle
CENTRAL INDEX KEY: 0001874962
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 23677155
MAIL ADDRESS:
STREET 1: C/O RUBIUS THERAPEUTICS, INC.
STREET 2: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O VERDOLINO & LOWEY, P.C.
STREET 2: 124 WASHINGTON STREET, SUITE 101
CITY: FOXBORO
STATE: MA
ZIP: 02035
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: C/O VERDOLINO & LOWEY, P.C.
STREET 2: 124 WASHINGTON STREET, SUITE 101
CITY: FOXBORO
STATE: MA
ZIP: 02035
4
1
tm237991-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-02-24
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001874962
Appelhans Dannielle
C/O VERDOLINO & LOWEY, P.C.
124 WASHINGTON ST.
FOXBOROUGH
MA
02035
0
1
0
0
CEO and President
Common Stock
2023-02-24
4
S
0
10385
0.1274
D
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1273 to $0.1274, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Dannielle Appelhans
2023-02-27